Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2400080270Phase 4Not yet recruiting
Phase 4, open-label trial of ropivacaine and sufentanil in labor pain (5 arms), sponsored by Jiashan First People's Hospital. Primary endpoints: VAS scores, PCEA pressing time and frequency and 1 more. Planned start Jan 2024; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2400080270.